Semaglutide (Ozempic, Novo Nordisk) is associated with a significantly lower risk for overdose in individuals with opioid use disorder (OUD), new research shows. The findings suggest that the drug ...
Retail offering for 1.5 million shares of Almajed for Oud Co. on Tadawul begins today, Sept. 15, at a price of SAR 94 per share, which was determined through the book-building process. The offering ...